Florian M. WurmProfessor Emeritus at Swiss Federal Institute of Technology Lausanne (EPFL)
His career involved industrial and academic work: Behringwerke AG, Marburg (1981-1984), Harvard Medical School Boston (1984-1985), Genentech Inc, San Francisco (1985-1995), Swiss Federal Institute of Technology, Lausanne (EPFL – full Professor for Biotechnology), (1995-2015), ExcellGene SA, Monthey, Suisse (2001-today). He contributed to the generation of several therapeutics such as Herceptin®. His academic research activities covers Process Sciences. He is co-founder of ExcellGene SA (2001), CEO (2015-2016) and CSO/Chairman (since 2017). Florian was Chairman of the European Society of Animal Cell Technology. Published papers/patents >250. He is a frequent speaker/lecturer on manufacturing sciences and regulatory issues.